Dernières nouvelles pour Myomo (AMEX:MYO) Stock

Myomo

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Myomo Inc

WIIM

SVCO

Silvaco Group shares are trading lower. The company reported Q4 financial results.

<p>Telsey Advisory Group  analyst Joseph Feldman   maintains Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Outperform and maintains $73 price target.</p>


News

Price Target

Analyst Ratings

Telsey Advisory Group Maintains Outperform on Kroger, Maintains $73 Price Target

CTOS

Custom Truck One Source shares are trading higher after Oppenheimer raised its price target on the stock from $5 to $6 and maintained its Outperform rating.

<p>Macquarie  analyst Paul Golding   maintains United Parks &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) with a Outperform and lowers the price target from $70 to $65.</p>


PRKS

Macquarie Maintains Outperform on United Parks & Resorts, Lowers Price Target to $65

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

TDOC

Teladoc Health shares are trading higher after the company announced a pharmacy integration agreement with Gifthealth for a GLP-1 self-pay option.

<p>Macquarie  analyst Paul Golding   maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Outperform and raises the price target from $30 to $31.</p>


NCLH

Macquarie Maintains Outperform on Norwegian Cruise Line, Raises Price Target to $31

TRML

Tourmaline Bio shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $42.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading lower following reports suggesting a federal judge ruled in favor of the FDA in the tirzepatide compounding case.

<p>Macquarie  analyst Paul Golding   maintains Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) with a Outperform and raises the price target from $146 to $165.</p>


Macquarie Maintains Outperform on Live Nation Entertainment, Raises Price Target to $165

HIPO

Hippo Holdings shares are trading higher following better-than-expected Q4 financial results.

RGTI

Rigetti Computing shares are trading higher, reversing after falling Wednesday on a Q4 revenue miss.

<p>Citigroup  analyst Daniel Grosslight   reiterates Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Sell and maintains $27 price target.</p>


Reiteration

Citigroup Reiterates Sell on Hims & Hers Health, Maintains $27 Price Target

<p>Financial giants have made a conspicuous bearish move on Astera Labs. Our analysis of options history for Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 40% of traders were bullish, while 60% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $192,986, and 4 were calls, valued at $164,488.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $120.0 for Astera Labs over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Astera Labs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Astera Labs's whale trades within a strike price range from $20.0 to $120.0 in the last 30 days. </p>
<h3>Astera Labs 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741277781_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.3</td>
<td>$1.05</td>
<td>$1.15</td>
<td>$90.00</td>
<td>$69.0K</td>
<td>2.6K</td>
<td align="right">34</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$53.5</td>
<td>$53.1</td>
<td>$53.1</td>
<td>$115.00</td>
<td>$53.1K</td>
<td>107</td>
<td align="right">10</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.5</td>
<td>$4.2</td>
<td>$4.32</td>
<td>$65.00</td>
<td>$43.2K</td>
<td>20</td>
<td align="right">150</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.9</td>
<td>$9.8</td>
<td>$9.8</td>
<td>$55.00</td>
<td>$31.3K</td>
<td>14</td>
<td align="right">62</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.9</td>
<td>$9.8</td>
<td>$9.8</td>
<td>$55.00</td>
<td>$29.4K</td>
<td>14</td>
<td align="right">30</td>
</tr>
</tbody>
</table>
</p>
<h3>About Astera Labs</h3>
<p>Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.</p>
<p>Following our analysis of the options activities associated with Astera Labs, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Astera Labs</h3>
<ul>
<li>Trading volume stands at 1,918,093, with ALAB's price down by -5.02%, positioned at $65.12.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 79 days.</li>
</ul>
<h3>Professional Analyst Ratings for Astera Labs</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $132.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $140.<br />
&#x2A; Consistent in their evaluation, an analyst from Craig-Hallum keeps a Buy rating on Astera Labs with a target price of $125. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Astera Labs options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

ALAB

This Is What Whales Are Betting On Astera Labs

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Zscaler</strong>.</p>
<p>Looking at options history for Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) we detected 13 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 69% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $72,242 and 11, calls, for a total amount of $501,065.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $240.0 for Zscaler, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Zscaler's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Zscaler's substantial trades, within a strike price spectrum from $120.0 to $240.0 over the preceding 30 days.</p>
<h3>Zscaler Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741277776_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$25.2</td>
<td>$24.45</td>
<td>$24.75</td>
<td>$240.00</td>
<td>$96.5K</td>
<td align="right">608</td>
<td align="right">35</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$12.0</td>
<td>$11.7</td>
<td>$12.0</td>
<td>$210.00</td>
<td>$66.0K</td>
<td align="right">587</td>
<td align="right">187</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$20.65</td>
<td>$20.1</td>
<td>$20.2</td>
<td>$230.00</td>
<td>$60.6K</td>
<td align="right">271</td>
<td align="right">38</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$5.25</td>
<td>$4.8</td>
<td>$5.25</td>
<td>$207.50</td>
<td>$47.2K</td>
<td align="right">218</td>
<td align="right">377</td>
</tr>
<tr>
<td>ZS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.44</td>
<td>$2.43</td>
<td>$2.43</td>
<td>$240.00</td>
<td>$46.1K</td>
<td align="right">761</td>
<td align="right">788</td>
</tr>
</tbody>
</table>
</p>
<h3>About Zscaler</h3>
<p>Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.</p>
<p>Having examined the options trading patterns of Zscaler, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Zscaler</h3>
<ul>
<li>Currently trading with a volume of 2,742,553, the ZS's price is up by 6.93%, now at $210.07. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 84 days.</li>
</ul>
<h3>What The Experts Say On Zscaler</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $236.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Zscaler with a target price of $233.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Zscaler with a target price of $250.<br />
&#x2A; An analyst from Wedbush has decided to maintain their Outperform rating on Zscaler, which currently sits at a price target of $240.<br />
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Zscaler, targeting a price of $210.<br />
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Zscaler, targeting a price of $250. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Zscaler with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Zscaler's Latest Options Trends

<p>Financial giants have made a conspicuous bearish move on Spotify Technology. Our analysis of options history for Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 23% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $227,134, and 9 were calls, valued at $1,491,231.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $210.0 and $575.0 for Spotify Technology, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Spotify Technology options trades today is 242.91 with a total volume of 449.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Spotify Technology's big money trades within a strike price range of $210.0 to $575.0 over the last 30 days.</p>
<h3>Spotify Technology Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741277770_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$181.85</td>
<td>$179.1</td>
<td>$179.1</td>
<td>$430.00</td>
<td>$591.0K</td>
<td align="right">82</td>
<td align="right">33</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$141.7</td>
<td>$139.3</td>
<td>$141.7</td>
<td>$460.00</td>
<td>$396.2K</td>
<td align="right">32</td>
<td align="right">28</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$12.4</td>
<td>$9.6</td>
<td>$9.6</td>
<td>$572.50</td>
<td>$144.0K</td>
<td align="right">18</td>
<td align="right">160</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$10.0</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$572.50</td>
<td>$139.5K</td>
<td align="right">18</td>
<td align="right">8</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$20.4</td>
<td>$19.4</td>
<td>$20.1</td>
<td>$470.00</td>
<td>$100.5K</td>
<td align="right">80</td>
<td align="right">51</td>
</tr>
</tbody>
</table>
</p>
<h3>About Spotify Technology</h3>
<p>Spotify is the leading global music streaming service provider, with nearly 700 million monthly active users and over 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.</p>
<p>Having examined the options trading patterns of Spotify Technology, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Spotify Technology's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 543,518, the SPOT's price is down by -2.28%, now at $573.47. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 47 days.</li>
</ul>
<h3>Professional Analyst Ratings for Spotify Technology</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $700.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Guggenheim has decided to maintain their Buy rating on Spotify Technology, which currently sits at a price target of $675.<br />
&#x2A; An analyst from Citigroup persists with their Neutral rating on Spotify Technology, maintaining a target price of $720.<br />
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Spotify Technology with a target price of $675.<br />
&#x2A; An analyst from Canaccord Genuity persists with their Buy rating on Spotify Technology, maintaining a target price of $700.<br />
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Spotify Technology, maintaining a target price of $730. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Spotify Technology, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


SPOT

Looking At Spotify Technology's Recent Unusual Options Activity

<p>JP Morgan  analyst Brian Cheng   maintains ITeos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) with a Overweight and lowers the price target from $22 to $15.</p>


ITOS

JP Morgan Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $15

<p>Russian Deputy Finance Minister <strong>Vladimir Kolychev</strong>'s statement on Wednesday that <strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) will not be included in the National Wealth Fund mirrors President <strong>Vladimir Putin</strong>'s <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42667932/did-vladimir-putin-just-ban-bitcoin-mining-in-russia-the-devil-is-in-the-details">historically cautious approach to cryptocurrency</a>.</p>
<p><strong>What Happened: </strong>Kolychev, <a href="https://www.interfax.ru/business/1011938">speaking</a> to Interfax on Wednesday, confirmed that the country&#8217;s national wealth fund will maintain its focus on gold and yuan, with allocations of up to 60% in yuan and 40% in gold, explicitly rejecting Bitcoin due to its volatility.</p>
<p>"From a sovereign budget reserve perspective, it is crucial that the fund's assets are highly liquid and can be quickly sold without significant loss in value," he said, adding, "Digital assets are highly volatile, so we have never considered them for the NWF and have no plans to do so in the future." </p>
<p>The NWF, valued at 11.97 trillion rubles ($122.09 billion) as of February 1, 2025—or 5.6% of projected 2025 GDP—falls below the 7-10% GDP threshold Kolychev cited for considering riskier assets, reinforcing the decision to exclude Bitcoin.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44151349/coinbase-rekindles-efforts-to-introduce-tokenized-securities-in-the-us">Coinbase Rekindles Efforts To Introduce Tokenized Securities In The US</a></strong></p>
<p><strong>Why It Matters: </strong>Putin's comments over the years provide a backdrop to this policy.</p>
<p>In 2021, he acknowledged Bitcoin's potential but flagged its instability, stating, "Bitcoin has value, but it's too unstable for oil trade," <a href="https://www.cnbc.com/2021/10/14/russias-putin-says-crypto-has-value-but-maybe-not-for-trading-oil.html">according</a> to a report.</p>
<p>This followed his 2017 push for regulation to curb risks like money laundering, a stance that evolved into a structured framework by 2024. </p>
<p>But his administration also banned crypto payments in 2022, reflecting a pattern of embracing crypto's utility—such as in international trade to counter sanctions—while restricting its role in domestic finance.</p>
<p>Putin's earlier engagement with blockchain, such as his 2017 meeting with Ethereum founder Vitalik Buterin at the St. Petersburg International Economic Forum, signaled openness to the technology's potential, but always within a controlled framework. </p>
<p>In December 2024, <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42317460/vladimir-putin-says-nobody-can-ban-bitcoin-stresses-crypto-will-develop-one-way-or-the-other">Putin famously said</a> that &#8220;nobody can ban Bitcoin,&#8221; emphasizing the power of decentralized technology.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44148430/bitscrunch-acquires-nidum-ai-to-build-decentralized-ai-compute-network">BitsCrunch Acquires Nidum AI To Build Decentralized AI Compute Network</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Media

$BTC

Vladimir Putin Said 'Nobody Can Ban Bitcoin,' But Russia Isn't Looking To Follow Donald Trump's Push For A Crypto Reserve

<p>Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) has outperformed the market over the past 5 years by 6.91% on an annualized basis producing an average annual return of 21.86%. Currently, Allison Transmission has a market capitalization of $8.30 billion. </p>
<p><strong>Buying $1000 In ALSN:</strong> If an investor had bought $1000 of ALSN stock 5 years ago, it would be worth <strong>$2,774.32</strong> today based on a price of $95.86 for ALSN at the time of writing.</p>
<h3>Allison Transmission's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741277709_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

ALSN

Here's How Much $1000 Invested In Allison Transmission 5 Years Ago Would Be Worth Today

GRRR

Gorilla Technology Group shares are trading lower following a report from The Bear Cave.

Press Releases

Myomo to Participate in Two Investor Conferences in September

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Myomo to Report Third Quarter Financial Results on November 6, 2024

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage

Myomo Reports Record Third Quarter Financial and Operating Results

Myomo, Inc. Announces Proposed Public Offering of Common Stock

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Myomo to Report Fourth Quarter 2024 Financial Results on March 10

INGN

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

BrainsWay Ltd. - American Depositary Shares

BrainsWay

CVRx

Alpha Tau Medical

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Myomo

Actualités

Dernières nouvelles pour Myomo (AMEX:MYO) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL